Contact UsInvestorsCareersMediaContact Us
Investor Relations

STATUTORY COMMUNICATIONS

Appointment of Mr. Ravi Prakash Bhagavathula as an Executive Director

Stock Exchange Intimation – Analyst Call – Financial Results for the quarter ended December 31, 2016

Notice of Board Meeting – January 30, 2017​​​​​​​

Granting of authority to the Company by AstraZeneca Pharma India Limited for certain rights in relation to identified injectable antibiotic products through a Delegation of Authority.

Stock Exchanges Intimation – Meeting with Analyst / Institutional Investor – January 12, 2017

Stock Exchanges Intimation – Meeting with Analyst / Institutional Investor – December 9, 2016Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.Appointment of Dr. Anurita Majumdar as Woman DirectorResignation of Ms. Lu Hong as Non-Executive Woman DirectorStock Exchange Intimation – Analyst Call – Results for the quarter ended September 30, 2016Notice of Board Meeting – November 4, 2016​​​​​​​Pfizer Limited – Completion of Transaction of the Sale of Four Products to Piramal Enterprises LimitedStock Exchanges Intimation – Meeting with Analyst / Institutional Investor – September 23, 2016​​​​​​​Stock Exchange Intimation – Analyst Call – Results for the quarter ended June 30, 2016​​​​​​​Notice of Board Meeting – August 5, 2016Pfizer Limited –65th AGM proceedingsStock Exchange Intimation – 65th AGM – remote e-voting and poll resultsPfizer Limited - Annual Report for the financial year ended March 31, 2016Stock Exchanges Intimation – Meeting with Analyst / Institutional Investor – June 15, 2016Stock Exchanges Intimation – Book Closure and 65th Annual General MeetingSE Intimation – Meeting with Analyst / Institutional Investor – May 20, 2016 (2)SE Intimation – Meeting with Analyst / Institutional Investor – May 20, 2016Pfizer Limited – Sale of Four Products to Piramal Enterprises LimitedStock Exchanges Intimation – Analysts call - Results for the year ended March 31, 2016Notice of Board Meeting – May 6, 2016SE Intimation – Meeting with Analyst / Institutional Investor – April 13, 2016​​​​​​​Stock Exchange intimation of Press Release by Pfizer Inc. USA – April 6, 2016
About UsOur PeopleOur Community EffortsOur ProductsInvestorsCareerMediaAdverse Event ReportingHealth Care ProfessionalsTerms of UsePrivacy PolicyContact UsCopyright © 2002- 2021 Pfizer Inc. All rights reserved.